在维护血液透析的患者中,米多德林和临床结果
Junseok Jeon1, Yu Jeong Lim2, Bo Yeon Kim2
1Division of Nephrology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Scientific reports
|July 3, 2025
概括
用于治疗血液透析患者的静脉透析性低血压 (IDH) 的米多德林与全因死亡率的剂量依赖性增加有关. 心血管事件在各组之间没有显著差异.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 临床结果研究研究
背景情况:
- 透析内低血压 (IDH) 是血液透析患者的常见并发症,与增加的发病率和死亡率有关.
- 米多德林是一种α-1上腺激素激动剂,经常用于管理或预防IDH.
- 米多德林对该人群的长期临床结果的确切影响仍然不完全理解.
研究的目的:
- 调查米多林处方与临床结果之间的关联,包括全因死亡率和心血管事件 (CVEs).
- 评估米多德林对维护血液透析患者死亡风险的剂量依赖性影响.
主要方法:
- 用质量评估和保险数据库的数据对大量血液透析患者进行回顾性分析.
- 倾向性得分匹配被用于控制基线差异,在患者处方 midodrine 和那些没有.
- 考克斯回归模型用于估计死亡率和CVE的危险比率 (HR) 和置信区间 (CI).
主要成果:
- 在研究的71540名患者中,约有9.6%的患者被处方米多德林.
- 在倾向性得分匹配后,米多德林的使用与因任何原因死亡的风险显著增加有关 (调整HR: 1.17;95%CI: 1.13-1.22).
- 观察到一种剂量依赖的关系,较高的midodrine剂量与较高的HR死亡率相关;在CVE风险上没有发现显著差异.
结论:
- 在血液透析患者中使用米多林与全因死亡率的剂量依赖性增加有关.
- 临床医生应优先管理并发病症和IDH风险因素,特别是当需要频繁服用米多德林时.
- 需要进一步的前性研究来验证这些发现,并纳入详细的IDH数据.
更多相关视频
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
9.9K
08:35Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
3.5K
相关概念视频
01:25Hemodialysis III: Nursing Management
196
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
196
01:24Hemodialysis II: Procedure and Complications
146
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
146
01:25Peritoneal Dialysis III: Nursing Management
157
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
157
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
639
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
639
01:27Dialysis
489
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
489
01:26Cholinergic Antagonists: Therapeutic Uses
884
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
884